Right heart function and scleroderma: Insights from tricuspid annular plane systolic excursion

Echocardiography

Volumn 24, Issue 2, 2007, Pages 118-125

  Lee, Chiu Yen ^a   Chang, Shu Mei ^a   Hsiao, Shih Hung ^a   Tseng, Jui Cheng ^a   Lin, Shih Kai ^a   Liu, Chun Peng ^a  

^a KAOHSIUNG VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

Pulmonary hypertension; Right heart; Scleroderma; Tissue Doppler imaging

Indexed keywords

ADULT; ARTICLE; CARDIOPULMONARY FUNCTION; CLINICAL ARTICLE; CONTROLLED STUDY; COURSE EVALUATION; DIAGNOSTIC ACCURACY; DIASTOLE; ELECTROCARDIOGRAPHY MONITORING; FEMALE; FOLLOW UP; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART RIGHT VENTRICLE EJECTION FRACTION; HEART RIGHT VENTRICLE FUNCTION; HOSPITALIZATION; HUMAN; MALE; PREDICTION; PRIORITY JOURNAL; PULMONARY ARTERY; SCLERODERMA; SYSTOLIC BLOOD PRESSURE; SYSTOLIC TIME INTERVAL; TRICUSPID VALVE;

ADULT; ECHOCARDIOGRAPHY, DOPPLER; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PATIENT READMISSION; PREDICTIVE VALUE OF TESTS; PROGNOSIS; SCLERODERMA, SYSTEMIC; STROKE VOLUME; SYSTOLE; TRICUSPID VALVE INSUFFICIENCY; VENTRICULAR FUNCTION, RIGHT;

EID: 33846837374     PISSN: 07422822     EISSN: 15408175     Source Type: Journal    
DOI: 10.1111/j.1540-8175.2007.00365.x     Document Type: Article

References (25)

1. D'Angelo WA, Fries JF, Masi AT, et al: Pathological observations in systemic sclerosis (scleroderma): A study of 58 autopsy cases and 58 matched controls. Am J Med 1969;46:428-440.
2. Bulkley BH, Ridolfi RL, Salyer WR, et al: Myocardial lesions of progressive systemic sclerosis, a cause of cardiac dysfunction. Circulation 1976;53:483-490.
3. Follansbee W, Miller T, Curtiss E, et al: A controlled clinicopathological study of myocardial fibrosis in systemic sclerosis (scleroderma). J Rheumatol 1990;17:656-662.
4. Smith JW, Clements PJ, Levisman J, et al: Echocardiographic features of progressive systemic sclerosis. Correlation with hemodynamic and post-mortem studies. Am J Med 1979;66:28-33.
5. Butrous GS, Dowd PM, Milne J, et al: Non-invasive assessment of early cardiac involvement in systemic sclerosis. Postgrad Med J 1985;61:679-684.
6. Morelli S, Sgreccia A, De Marzio P, et al: Noninvasive assessment of myocardial involvement in patients with systemic sclerosis: Role of signal averaged electrocardiography. J Rheumatol 1997;24:2358-2363.
7. Kazzam E, Caidhal K, Lendelius J, et al: Non-invasive assessment of left ventricular diastolic function in patients with scleroderma. J Intern Med 1990;228:182-193.
8. Fujimoto S, Kagoshima T, Nakajima T, et al: Doppler echocardiographic assessment of left ventricular diastolic function in patients with systolic sclerosis. Cardiology 1993;82:217-227.
9. Valentini G, Vitale DF, Giunta A, et al: Diastolic abnormalities in systemic sclerosis: Evidence for associated defective cardiac functional reserve. Ann Rheum Dis 1996;55:455-460.
10. Armstrong GP, Whalley GA, Doughty RN, et al: Left ventricular function in scleroderma. Br J Rheumatol 1996;35:983-988.
11. Candell-Riera J, Armadans-Gil L, Simeon CP, et al: Comprehensive noninvasive assessment of cardiac involvement in limited systemic sclerosis. Arthritis Rheum 1996;39:1138-1145.
12. Kaul S, Tei C, Hopkin JM, et al: Assessment of right ventricular function using two-dimensional echocardiography. Am Heart J 1984;107:526-531.
13. Ghio S, Recusani F, Klersy C, et al: Prognostic usefulness of the tricuspid annular plane systolic excursion in patients with congestive heart failure secondary to idiopathic or ischemic dilated cardiomyopathy. Am J Cardiol 2000;85:837-842.
14. Popescu BA, Antonini-Canterin F, Temporelli PL, et al: Right ventricular functional recovery after acute myocardial infarction: Relation with left ventricular function and interventricular septum motion. GISSI-3 echo substudy. Heart 2005;91:484-488.
15. Chang B, Wigley FM, White B, et al: Scleroderma patients with combined pulmonary hypertension and interstitial lung disease. J Rheumatol 2003;30:2398-2405.
16. Mukerjee D, St George D, Coleiro B, et al: Prevalence and outcome in systemic sclerosis associated pulmonary arterial hypertension: Application of a registry approach. Ann Rheum Dis 2003;62:1088-1093.
17. Kawut SM, Taichman DB, Archer-Chicko CL, et al: Hemodynamics and survival in patients with pulmonary arterial hypertension related to systemic sclerosis. Chest 2003;123:344-350.
18. Morgan C, Knight C, Lunt M, et al: Predictors of end stage lung disease in a cohort of patients with scleroderma. Ann Rheum Dis 2003;62:146-150.
19. Clements PJ, Lachenbruch PA, Furst DE, et al: Cardiac score. A semiquantitative measure of cardiac involvement that improves prediction of prognosis in systemic sclerosis. Arthritis Rheum 1991;34:1371-1380.
20. D'Alonzo GE, Barst RJ, Ayres SM, et al: Survival in patients with primary pulmonary hypertension. Ann Intern Med 1991;115:343-349.
21. Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980;23:581-590.
22. Miller D, Farah MG, Liner A, et al: The relation between quantitative right ventricular ejection fraction and indices of tricuspid annular motion and myocardial performance. J Am Soc Echocardiogr 2004;17:443-447.
23. Battle RW, Davitt MA, Cooper SM, et al: Prevalence of pulmonary hypertension in limited and diffuse scleroderma. Chest 1996;110:1515-1519.
24. Kircher BJ, Himelman RB, Schiller NB: Noninvasive estimation of right atrial pressure from the inspiratory collapse of the inferior vena cava. Am J Cardiol 1990;66:493-496.
25. Janosik DL, Osborn TG, Moore TL, et al: Heart disease in systemic sclerosis. Semin Arthritis Rheum 1989;19:191-220.